Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.

D. Gully, M. Canton, Robert Boigegrain, +7

Proceedings of the National Academy of Sciences

Neurotensin ReceptorPharmacotherapySocial SciencesMolecular PharmacologyNeurology +17

Biochemical and Pharmacological Activities of SR 142948A, a New Potent Neurotensin Receptor Antagonist

Danielle Gully, Bernard Labeeuw, Robert Boigegrain, +13

Journal of Pharmacology and Experimental Therapeutics

SR146131: A New Potent, Orally Active, and Selective Nonpeptide Cholecystokinin Subtype 1 Receptor Agonist. I: In Vitro Studies

Eric Bignon, André Bachy, Robert Boigegrain, +19

Journal of Pharmacology and Experimental Therapeutics

Inhibition of rat colon motility by stimulation of atypical beta-adrenoceptors with new gut-specific agents

Tiziano Croci, R. Cecchi, Antonio Tarantino, +3

Pharmacological Research Communications

Functional Gastrointestinal DisorderMedicinePhysiologyGastroenterologyGut-organ Axis +7

Synthesis and β-adrenergic activity of atypical β-adrenergic phenylethanolaminotetralin stereoisomers

R. Cecchi, Tiziano Croci, Robert Boigegrain, +5

European Journal of Medicinal Chemistry

Molecular PharmacologyMedicineOrganic ChemistryStereoselective SynthesisPharmacology +2

SR146131: A New Potent, Orally Active, and Selective Nonpeptide Cholecystokinin Subtype 1 Receptor Agonist. II: In Vivo Pharmacological Characterization

Eric Bignon, Richard Alonso, M. Arnone, +15

Journal of Pharmacology and Experimental Therapeutics

Neurotensin receptor interaction with dopaminergic systems in the guinea-pig brain shown by neurotensin receptor antagonists

Mounia Azzi, Danielle Gully, Michel Héaulme, +7

European Journal of Pharmacology

Dopaminergic SystemsNeurophysiologyNeuroanatomySympathetic Nervous SystemPhysiology +13

SR 46559 A and related aminopyridazines are potent muscarinic agonists with no cholinergic syndrome

Camille G. Wermuth, Jean‐Jacques Bourguignon, Rémy D. Hoffmann, +4

Bioorganic & Medicinal Chemistry Letters

Molecular PharmacologyPotent Muscarinic AgonistsMedicinePsychotropic MedicationCholinergic Syndrome +7

Kappa binding sites in guinea-pig brain membranes: Evidence for a dynorphin-resistant subtype

Michel Morre, André Bachy, Bernard Gout, +3

Life Sciences

Molecular NeuroscienceMolecular PhysiologyNeuroanatomyDynorphin-resistant SubtypePhysiology +11

Structural requirements of non-peptide neurotensin receptor antagonists

Luc Quéré, Robert Boigegrain, Francis Jeanjean, +3

Journal of the Chemical Society Perkin Transactions 2

Bioactive ConformationMolecular PharmacologyHypertensionBiochemistryStructural Requirements +13